Yasuhiro Abe Selected Research

Prednisolone (Predate)

1/2021	Concurrent minimal change disease and retroperitoneal liposarcoma successfully treated by tumor resection and steroid therapy.
1/2017	Benefits of High-dose Steroid + Hespander + Mannitol Administration in the Treatment of Bell's Palsy.
1/2016	[A case of AKI-caused minimal change nephrotic syndrome with concomitant pleuritis].
1/2007	Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Abe Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 03/2004
5	Inflammation (Inflammations) 10/2016 - 03/2004
5	Infections 12/2014 - 07/2009
5	Chronic Kidney Failure (Chronic Renal Failure) 11/2014 - 05/2007
4	Proteinuria 01/2021 - 01/2007
4	Breast Neoplasms (Breast Cancer) 09/2014 - 01/2011
4	Rheumatoid Arthritis 01/2010 - 01/2008
3	Glomerulonephritis 10/2016 - 01/2013
3	Autoimmune Diseases (Autoimmune Disease) 02/2015 - 08/2009
3	Virus Diseases (Viral Diseases) 01/2010 - 12/2009
3	Hepatitis 08/2009 - 01/2008
2	Diabetes Mellitus 01/2021 - 01/2012
2	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2018
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2013
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2009
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2012
2	Bell Palsy (Bell's Palsy) 01/2017 - 01/2007
2	Fever (Fevers) 01/2016 - 01/2010
2	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 01/2016
2	Amyloidosis 01/2016 - 01/2007
2	Neoplasm Metastasis (Metastasis) 07/2015 - 12/2013
2	Lung Neoplasms (Lung Cancer) 07/2015 - 02/2011
2	Nephritis 12/2014 - 01/2010
2	Crohn Disease (Crohn's Disease) 01/2010 - 06/2008
2	Body Weight (Weight, Body) 10/2009 - 01/2009
2	Necrosis 08/2009 - 03/2004
1	Abscess 01/2021
1	Retroperitoneal liposarcoma 01/2021
1	Hypercholesterolemia 01/2021
1	Edema (Dropsy) 01/2021
1	COVID-19 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Urinary Tract Infections (Urinary Tract Infection) 11/2019
1	Hypertension (High Blood Pressure) 04/2019
1	Heart Failure 04/2019
1	Hemorrhage 01/2019
1	Polyps 01/2019
1	Hyperlipidemias (Hyperlipidemia) 11/2018
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 10/2016 - 09/2004
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 03/2004
8	Type I Tumor Necrosis Factor ReceptorsIBA 02/2015 - 01/2008
6	CytokinesIBA 12/2014 - 01/2009
5	Pharmaceutical PreparationsIBA 09/2014 - 01/2009
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 01/2007
4	Messenger RNA (mRNA)IBA 10/2016 - 01/2013
4	antineoplaston A10 (A 10)IBA 09/2014 - 01/2011
4	Therapeutic UsesIBA 01/2011 - 01/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
3	AA amyloidosisIBA 01/2016 - 01/2007
3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2007
3	ProteomeIBA 07/2015 - 02/2011
3	Type II Tumor Necrosis Factor ReceptorsIBA 02/2015 - 10/2009
3	EphA1 Receptor (Eph Receptor)IBA 07/2014 - 01/2011
3	Silicon Dioxide (Silica)FDA LinkGeneric 10/2012 - 05/2011
3	Blood Glucose (Blood Sugar)IBA 01/2012 - 01/2009
2	SteroidsIBA 01/2021 - 01/2017
2	LDL CholesterolIBA 01/2021 - 03/2010
2	oxidized low density lipoproteinIBA 01/2021 - 03/2010
2	Apolipoproteins E (ApoE)IBA 11/2018 - 10/2012
2	Protein Isoforms (Isoforms)IBA 11/2018 - 01/2010
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2016 - 01/2010
2	Biological ProductsIBA 02/2015 - 09/2004
2	Monoclonal AntibodiesIBA 09/2014 - 07/2014
2	AntigensIBA 01/2013 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 04/2012 - 01/2011
2	Urea (Carbamide)FDA LinkGeneric 01/2012 - 10/2009
2	CholesterolIBA 01/2012 - 10/2009
2	NitrogenIBA 01/2012 - 10/2009
2	AdiponectinIBA 01/2012 - 01/2010
2	Triglycerides (Triacylglycerol)IBA 01/2012 - 10/2009
2	CreatinineIBA 01/2012 - 10/2009
2	Antineoplastic Agents (Antineoplastics)IBA 12/2004 - 03/2004
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	ciclesonide FDA Link 12/2020
1	flomoxefIBA 11/2019
1	beta-Lactamases (beta-Lactamase)IBA 11/2019
1	Cefmetazole (Cefmetazole Sodium)FDA Link 11/2019
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 04/2019
1	Valsartan (Vals)FDA Link 04/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	AnticoagulantsIBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 11/2018
1	Apolipoprotein E3IBA 11/2018
1	apolipoprotein E5IBA 11/2018
1	Advanced Glycation End ProductsIBA 06/2017
1	Pyruvaldehyde (Methylglyoxal)IBA 06/2017

Therapy/Procedure

13	Therapeutics 01/2021 - 05/2006
6	Renal Dialysis (Hemodialysis) 01/2016 - 05/2007
4	Drug Therapy (Chemotherapy) 06/2011 - 03/2004
1	Blood Component Removal (Apheresis) 01/2021
1	Splenectomy 01/2021
1	Pancreatectomy 01/2021
1	Metered Dose Inhalers (Metered Dose Inhaler) 12/2020
1	Inhalation Spacers 12/2020
1	Endoscopic Hemostasis 01/2019